The purpose of this course is to provide an integrated update of the recent developments on the pathophysiology of migraine and resulting "mechanism-related" therapies, to evaluate the clinical benefit-risk ratio of antimigraine medications, and to summarize the current and evidence-based guidelines for the clinical management of migraine. The information provided should contribute to a more positive interaction between patients and healthcare professionals, through fostering patient awareness, implementation of lifestyle changes, and compliance to therapy. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.
Upon completion of this course, you should be able to:
1. Discuss the incidence and prevalence of migraine in North America and compare with the epidemiologic data from other developed as well as developing countries.
2. Provide an updated overview of the progress made in the understanding of migraine pathophysiology.
3. Review the clinical profiles and diagnostic criteria of migraine with or without aura, and summarize disease staging.
4. Provide an update overview of the differential diagnosis of migraines focusing on medical and dental conditions, such as temporomandibular disorders, sinusitis, and orofacial pain.
5. Discuss the preventive and acute treatment of migraine.
This 5-hour continuing education course is available for download for professional development; if continuing education credit is desired, please see instructions included in eBook.